NBY earnings: a positive outcome, +5.7%

On November 9, 2023, NovaBay Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.7% in the window around the event. It had already run -12.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.